FTNT vs TGTX · P/E 56, rev $3.90B vs P/E 18, rev $240.3M
Fortinet Inc (FTNT) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported FTNT revenue for 2026-06-30 was $3.90B. Net income was $1.14B. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the FTNT and TGTX stock pages for the full models.
Not investment advice.